Physician profile
Stuart Wasser
NPI 1922099852
$13,383.34
in general payments reported to CMS, 2019-2025
32 companies · $710 in 2025
The $710 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $529 · 2020: $860 · 2021: $763 · 2022: $778 · 2023: $9,120 · 2024: $622 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,072 · Food and Beverage: $2,205 · Travel and Lodging: $144 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,071.88 |
| Food and Beverage | $2,205.12 |
| Travel and Lodging | $143.58 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $8,716.61 | 2022-2024 | Quviviq |
| Novo Nordisk INC | $562.83 | 2019-2024 | Wegovy, Ozempic |
| Alkermes, INC. | $521.79 | 2019-2025 | Vivitrol, Vivitrol |
| Ironshore Pharmaceuticals INC. | $509.59 | 2019-2022 | |
| Braeburn INC. | $500.86 | 2023-2025 | Brixadi |
| Indivior INC. | $314.84 | 2019-2025 | Sublocade |
| Orexo US, INC. | $288.95 | 2019-2025 | Zubsolv |
| Lundbeck LLC | $259.36 | 2020-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $223.15 | 2020-2023 | Belsomra |
| Uswm, LLC | $189.64 | 2021-2024 | Lucemyra |
| Allergan, INC. | $171.57 | 2019-2020 | |
| Axsome Therapeutics, INC. | $170.07 | 2024-2025 | Auvelity |
| Mdd US Operations, LLC | $153.55 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $113.15 | 2022-2025 | Rexulti |
| Abbvie INC. | $111.48 | 2021-2023 | Vraylar |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $80.20 | 2020-2024 | Jardiance, Zepbound |
| Eisai INC. | $69.98 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.12 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $52.80 | 2019 | |
| Renalytix Ai, INC. | $47.32 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Teva Pharmaceuticals USA, INC. | $39.25 | 2019-2025 | Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.50 | 2025 | Caplyta |
| Exact Sciences Corporation | $25.66 | 2024 | Cologuard Collection Kit |
| Shire North American Group INC | $24.62 | 2019 | |
| Corium, LLC | $23.62 | 2024 | Azstarys |
| Arbor Pharmaceuticals, INC. | $23.31 | 2021 | |
| Glaxosmithkline, LLC. | $22.03 | 2023 | Shingrix |
| Sanofi-Aventis U.S. LLC | $20.10 | 2019 | |
| Circassia INC. | $18.12 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.38 | 2022 | |
| Metacel Pharmaceuticals LLC | $15.38 | 2022 | |
| Horizon Therapeutics Plc | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Wasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.